Artikel ; Online: Adverse cardiovascular events are common during dexmedetomidine administration in neonates and infants during intensive care.
Acta paediatrica (Oslo, Norway : 1992)
2023 Band 112, Heft 11, Seite(n) 2338–2345
Abstract: Aim: This study aimed to assess the safety of a commonly used sedative, dexmedetomidine in neonates and infants during intensive care.: Methods: A retrospective cohort study was conducted in the paediatric intensive care unit at Oulu University ... ...
Abstract | Aim: This study aimed to assess the safety of a commonly used sedative, dexmedetomidine in neonates and infants during intensive care. Methods: A retrospective cohort study was conducted in the paediatric intensive care unit at Oulu University Hospital. The study population consisted of all children from birth up to 6 months of age who received dexmedetomidine during 2010-2016. Adverse cardiovascular outcomes were defined as abnormal heart rates or blood pressure values according to the Paediatric Early Warning Score. Results: Of the 172 infants, 56% had congenital malformation, and 48% had undergone surgery. Neonates and 1-3-month-olds experienced bradycardia (86% vs. 73% in 1-3-month-olds and 50% in 3-6-month-olds, p = 0.001) and severe bradycardia (17% vs. 14% in 1-3-month-olds and 0% in 3-6-month-olds, p = 0.005) more often than older patients. The median maximum rate of dexmedetomidine infusion was 0.86 μg/kg/h (IQR = 0.60-1.71 μg/kg/h). A dose-dependent increase in bradycardia and severe hypotension was found. Adverse cardiovascular events were managed with additional fluid boluses and discontinuation of the infusion. Conclusion: Adverse cardiovascular events were common during dexmedetomidine administration in neonates and infants. Lower dexmedetomidine doses may be required in sedating neonates. |
---|---|
Mesh-Begriff(e) | Infant, Newborn ; Child ; Humans ; Infant ; Dexmedetomidine/adverse effects ; Bradycardia/chemically induced ; Bradycardia/epidemiology ; Retrospective Studies ; Hypnotics and Sedatives/adverse effects ; Critical Care |
Chemische Substanzen | Dexmedetomidine (67VB76HONO) ; Hypnotics and Sedatives |
Sprache | Englisch |
Erscheinungsdatum | 2023-08-11 |
Erscheinungsland | Norway |
Dokumenttyp | Journal Article |
ZDB-ID | 203487-6 |
ISSN | 1651-2227 ; 0365-1436 ; 0803-5253 |
ISSN (online) | 1651-2227 |
ISSN | 0365-1436 ; 0803-5253 |
DOI | 10.1111/apa.16933 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Um IV Zs.95: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.